NCT00075205View on ClinicalTrials.gov

Rimonabant to Reduce Alcohol Consumption

PHASE2CompletedINTERVENTIONAL

Enrollment

54

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

March 15, 2007

Study Completion Date

March 15, 2007

Conditions

HealthyAlcohol Drinking

Interventions

DRUG

SR141716 (Rimonabant)

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

Sponsors

Collaborators (1)

Sanofi-Synthelabo

All Listed Sponsors

collaborator

Sanofi-Synthelabo

INDUSTRY

lead

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH